A Financially Sustainable Remote Treatment for Alcohol Abuse: Feasibility

经济上可持续的酒精滥用远程治疗:可行性

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Nearly 18% of United States adults meet criteria for alcohol dependence sometime in their lifetime, with only 24% of those individuals ever receiving any treatment for their disorder. Nearly 30% of people who meet criteria for alcohol abuse or dependence have considered seeking treatment, but have not done so. The pervasiveness of alcohol dependence indicates a need for continued development of high-impact treatments that are both effective and easily disseminated to a broad population. Contingency management, or the delivery of monetary incentives contingent on verified abstinence, is an effective treatment for drug and alcohol abuse. However, the cost of incentive payments for abstinence and technological barriers to accurate, frequent biochemical verification of alcohol abstinence limit the use of this technique for the treatment of alcohol dependence. Deposit contracts, where the participant contributes to their own incentive fund up front, have been shown to reduce or eliminate incentive costs in similar treatments. Also, a breathalyzer has recently been developed with technological features that make it ideally suited for use in a contingency management intervention. This breathalyzer has the capacity to remotely verify abstinence from alcohol and contains a number of features to verify the identity of the user and prevent tampering. In the present application, we propose to use deposit contracts and this breathalyzer to facilitate a contingency-management intervention to reduce alcohol use that requires no in-person contact between the participants and the study staff during the intervention phase and is cost effective. To this end, we propose two specific aims. First, we will determine the feasibility of remotely-delivered contingency management trial to reduce alcohol use by using technological advances to overcome barriers in treatment delivery. We will conduct a randomized, controlled two-group feasibility study with a Contingent and Noncontingent group. The Contingent group will provide a deposit and then receive nearly immediate monetary payments over the internet each day they remotely provide negative breathalyzer samples. The Noncontingent group will also provide a deposit and receive payments each day they successfully provide samples independent of the alcohol content of those samples. Our first Specific Aim is to determine whether the contingency management intervention reduces alcohol use in the Contingent group to a greater extent than the Noncontingent group. In our second Specific Aim, we will assess participant ratings of acceptability and usefulness of these novel technologies. Poor ratings of acceptability or usefulness may suggest challenges of compliance and further dissemination. As potential treatment vehicles, it is important to assess whether the various technological tools and procedures used in this feasibility trial are viewed as effective and acceptable among individuals who are interested in reducing or ceasing their alcohol use. Together these specific aims will allow us to determine if remote, verified alcohol monitoring combined with deposit contracts is an effective treatment for alcohol dependence that is well accepted by participants.
 描述(通过应用程序证明):近18%的美国成年人的酒精饮酒一生中有24%的人接受过任何治疗的人,近30%或依赖性都没有寻求治疗,但没有寻求治疗。这样做。访问酒精戒酒限制的验证。在呼吸器中,呼吸器可以从酒精中验证,并在介绍应用中包含许多功能,并在展示应用中使用。这需要在干预阶段进行研究人员之间的亲密关系。治疗。每天使用互联网的欧盟可行性。比thanting的能力和有用的技术相比,在这种可行性中使用的各种技术工具和程序。不适,让我们确定远程,经过验证的酒精监测是否是对酒精依赖的有效信任,这是由icipant很好地解释的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mikhail Nikolaas Koffarnus其他文献

Mikhail Nikolaas Koffarnus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mikhail Nikolaas Koffarnus', 18)}}的其他基金

AppalTRuST Project 3: Impact of proposed tobacco product rules in Appalachia on consumption and product switching with the Experimental Tobacco Marketplace
AppalTRuST 项目 3:阿巴拉契亚拟议烟草产品规则对实验烟草市场消费和产品转换的影响
  • 批准号:
    10665322
  • 财政年份:
    2023
  • 资助金额:
    $ 24.76万
  • 项目类别:
Remote alcohol monitoring to facilitate abstinence reinforcement with an underserved population
远程酒精监测有助于服务不足的人群加强戒酒
  • 批准号:
    10251200
  • 财政年份:
    2018
  • 资助金额:
    $ 24.76万
  • 项目类别:
Remote alcohol monitoring to facilitate abstinence reinforcement with an underserved population
远程酒精监测有助于服务不足的人群加强戒酒
  • 批准号:
    10482379
  • 财政年份:
    2018
  • 资助金额:
    $ 24.76万
  • 项目类别:
Remote alcohol monitoring to facilitate abstinence reinforcement with an underserved population
远程酒精监测有助于服务不足的人群加强戒酒
  • 批准号:
    10015192
  • 财政年份:
    2018
  • 资助金额:
    $ 24.76万
  • 项目类别:
Neural Correlates of Choices for Impulsive HIV-risk Behavior in Stimulant Dependence
兴奋剂依赖中冲动性艾滋病毒风险行为选择的神经相关性
  • 批准号:
    9086338
  • 财政年份:
    2015
  • 资助金额:
    $ 24.76万
  • 项目类别:
Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility
远程酒精监测以促进戒酒强化:可行性
  • 批准号:
    8771552
  • 财政年份:
    2014
  • 资助金额:
    $ 24.76万
  • 项目类别:

相似国自然基金

兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
  • 批准号:
    72302197
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
  • 批准号:
    72332003
  • 批准年份:
    2023
  • 资助金额:
    166 万元
  • 项目类别:
    重点项目
异常获利、捐赠与会计信息操纵:基于新冠疫情的准自然实验研究
  • 批准号:
    72372061
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
签字注册会计师动态配置问题研究:基于临阵换师视角
  • 批准号:
    72362023
  • 批准年份:
    2023
  • 资助金额:
    28 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
为 MedStar Health 接受肺癌筛查的患者提供烟草治疗:一项随机试验
  • 批准号:
    10654115
  • 财政年份:
    2023
  • 资助金额:
    $ 24.76万
  • 项目类别:
Antibody-based therapy for fentanyl-related opioid use disorder
基于抗体的芬太尼相关阿片类药物使用障碍治疗
  • 批准号:
    10831206
  • 财政年份:
    2023
  • 资助金额:
    $ 24.76万
  • 项目类别:
Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods Approach
与阿片类药物使用障碍药物相关的口腔并发症的风险比较:混合方法
  • 批准号:
    10765049
  • 财政年份:
    2023
  • 资助金额:
    $ 24.76万
  • 项目类别:
Determining the Influence of Clinicodemographic, Biologic and SDOH Factors in Racial and Ethnic Disparities in the Prognosis of Alcohol-Associated Liver Disease
确定临床人口统计学、生物和 SDOH 因素对酒精相关性肝病预后中种族和民族差异的影响
  • 批准号:
    10785492
  • 财政年份:
    2023
  • 资助金额:
    $ 24.76万
  • 项目类别:
Improving outcomes for substance-affected families in the child welfare system
改善儿童福利系统中受药物影响的家庭的成果
  • 批准号:
    10734742
  • 财政年份:
    2023
  • 资助金额:
    $ 24.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了